Market Research Logo

Global Non-Invasive Prenatal Testing (NIPT) Market: Focus on Tests, Methods, Platforms, Applications, 26 Countries’ Analysis, Patent Landscape, and Competitive Landscape - Analysis and Forecast, 2018-2028

Global Non-Invasive Prenatal Testing (NIPT) Market: Focus on Tests, Methods, Platforms, Applications, 26 Countries’ Analysis, Patent Landscape, and Competitive Landscape - Analysis and Forecast, 2018-2028

The life science industry is focused on the development of advanced NIPT tests using genome sequencing technologies for the early detection of genetic disorders. The increasing prevalence of genetic disorders and development of the healthcare infrastructure are promoting the adoption of the NIPT for better diagnosis and improved prenatal care.

Non-invasive prenatal testing (NIPT) is a sophisticated method used for the screening of chromosomal abnormalities developing in the fetus. Currently, NIPT is considered as a valuable test for the pregnant women to provide cost-effective and highly efficient early diagnosis of genetic disorders. Moreover, advancements in genome sequencing technologies reduce turnaround time and the complexity of diagnosis with next generation sequencing (NGS). The NGS technology provides several opportunities to develop the non-invasive diagnostic procedures for an early and accurate detection of various genetic disorders. The life science industry is witnessing significant growth of NIPT tests developed using the NGS technology. Several biotechnology companies are now indulging in the research and development of such NGS-based NIPT products. Furthermore, the advent of genome sequencing technologies in the life science industry has enabled the companies to detect the genetic diseases at an early stage and provide accurate results to remain competitive in the market.

The purpose of this study is to gain a holistic view of the NIPT market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the tests associated with the global NIPT market across different regions. The market has been segmented into ‘tests,’ ‘methods,’ ‘platforms,’ ‘applications,’ and ‘regions.’ The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering various aspects of the global NIPT market with the help of the key factors driving the market, restraints, and challenges that can inhibit the overall market growth and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global NIPT market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment, the key market trends, list of the key companies, and the key strategies and developments have also been discussed.

The answers to the following key questions can be derived from this report:

  • How did the NIPT market evolve, and what is its scope in the future?
  • What are the major market drivers, challenges, and opportunities in the global NIPT market?
  • What are the key developmental strategies that are implemented by the key players to sustain in this market?
  • How the influencing factors will affect the industry attractiveness?
  • How NIPT is utilized for the detection of chromosomal abnormalities?
  • How investments by public and private companies and government organizations will affect the global NIPT market?
  • What was the market size of the leading segments and sub-segments of the global NIPT market in 2017?
  • How will the industry evolve during the forecast period 2018-2028?
  • What will be the growth rate of the NIPT during the forecast period?
  • How will each segment of the global NIPT market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2028?
  • Which test segment, and application segment is expected to register the highest CAGR for the NIPT market?
  • What is the market size of NIPT in different countries of the world?
  • Which geographical region will contribute to the highest sales of NIPT?
  • Who are the key players in the NIPT market, and what are their contributions?
The key players who have been contributing significantly to the NIPT market include Agilent Technologies, Inc., Annoroad Gene Technology, Berry Genomics Co., Ltd., BGI Diagnosis, Centogene AG, Counsyl, Inc., Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., Next Biosciences, NIPD Genetics, PerkinElmer, Inc., Premaitha Health Plc, and Quest Diagnostics Incorporated, among others.


Executive Summary
1 Market Overview
1.1 Introduction
1.2 NIPT Approach
1.3 Different Methods of NIPT
1.4 Benefits and Risks Associated with NIPT
1.5 Technological Advancements
1.6 World Economic Outlook of Prenatal Testing Market, 2017
1.7 Global NIPT Market Scenario
1.8 Assumptions and Limitations for Market Size Calculations
2 Market Dynamics
2.1 Overview
2.2 Impact Analysis
2.3 Market Drivers
2.4 Market Restraints
2.5 Market Opportunities
3 Competitive Landscape
3.1 Introduction
3.2 Key Developments and Strategies
3.2.1 Product Launches and Enhancements
3.2.2 Joint Ventures, Partnerships, and Collaborations
3.2.3 Mergers and Acquisitions
3.2.4 Business Expansions, Awards, Recognitions, Certifications, and Others
3.3 Market Share Analysis
3.4 Growth Share Matrix (by Test), 2017
3.5 Growth Share Matrix (by Region), 2017
3.6 Key Stakeholders of NIPT Market
3.7 Industry Attractiveness
3.7.1 Bargaining Power of Suppliers
3.7.2 Bargaining Power of Buyers
3.7.3 Threat of New Entrants
3.7.4 Threat of Substitute Products
3.7.5 Intensity of Competitive Rivalry
4 Industry Insights
4.1 Introduction
4.2 Patent Analysis
4.3 Clinical Laboratory Improvement Amendments (CLIA) Program
4.4 List of Regulatory Bodies
5 Global Non-Invasive Prenatal Testing (NIPT) Market (by Test)
5.1 Overview
5.2 Verifi
5.3 MaterniT21 PLUS and MaterniT GENOME
5.4 PrenaTest, GeneSafe, and PrenatalSAFE
5.5 Panorama
5.6 QNatal Advanced
5.7 Harmony
5.8 IONA
5.9 NIFTY
5.10 Bambni
5.11 Others
6 Global Non-Invasive Prenatal Testing (NIPT) Market (by Method)
6.1 Overview
6.2 cf-DNA
6.3 FCMB
7 Global Non-Invasive Prenatal Testing (NIPT) Market (by Platform)
7.1 Overview
7.2 NGS
7.3 MPSS
7.4 Others
8 Global Non-Invasive Prenatal Testing (NIPT) Market (by Application)
8.1 Overview
8.2 Trisomy Detection
8.3 Microdeletion Detection
8.4 Others
9 Global Non-Invasive Prenatal Testing (NIPT) Market (by Region)
9.1 Overview
9.2 Global Insights
9.3 North America
9.3.1 North America Market Dynamics
9.3.2 North America Market (by Country)
9.3.2.1 The U.S.
9.3.2.2 Canada
9.4 Europe
9.4.1 Europe Market Dynamics
9.4.2 Europe Market (by Country)
9.4.2.1 The U.K.
9.4.2.2 Germany
9.4.2.3 France
9.4.2.4 Italy
9.4.2.5 Spain
9.4.2.6 The Netherlands
9.4.2.7 Belgium
9.4.2.8 Switzerland
9.4.2.9 Sweden
9.4.2.10 Denmark
9.4.2.11 Poland
9.4.2.12 Russia
9.4.2.13 Rest-of-Europe
9.5 Asia-Pacific
9.5.1 Asia-Pacific Market Dynamics
9.5.2 Asia-Pacific (by Country)
9.5.2.1 China
9.5.2.2 Japan
9.5.2.3 Australia
9.5.2.4 India
9.5.2.5 Singapore
9.5.2.6 Hong Kong
9.5.2.7 Malaysia
9.5.2.8 Indonesia
9.5.2.9 Vietnam
9.5.2.10 South Korea
9.5.2.11 Philippines
9.5.2.12 Thailand
9.5.2.13 Rest-of-Asia-Pacific
9.6 Rest-of-the-World
10 Company Profiles
10.1 Overview
10.2 Agilent Technologies, Inc.
10.2.1 Overview
10.2.2 Corporate Summary
10.2.3 Product Offerings for Global NIPT Market
10.2.4 Financials
10.2.4.1 Financial Summary
10.2.5 SWOT Analysis
10.3 Annoroad Gene Technology
10.3.1 Overview
10.3.2 Corporate Summary
10.3.3 Product Offerings for Global NIPT Market
10.3.4 SWOT Analysis
10.4 Berry Genomics Co., Ltd.
10.4.1 Overview
10.4.2 Corporate Summary
10.4.3 Product Offerings for Global NIPT Market
10.4.4 SWOT Analysis
10.5 BGI Diagnosis
10.5.1 Overview
10.5.2 Corporate Summary
10.5.3 Product Offerings for Global NIPT Market
10.5.4 SWOT Analysis
10.6 Centogene AG
10.6.1 Overview
10.6.2 Corporate Summary
10.6.3 Product Offerings for Global NIPT Market
10.6.4 SWOT Analysis
10.7 Counsyl, Inc. (Subsidiary of Myriad Genetics, Inc.)
10.7.1 Overview
10.8 Myriad Genetics, Inc.
10.8.1 Overview
10.8.2 Corporate Summary
10.8.3 Product Offerings for Global NIPT Market
10.8.4 Financials
10.8.4.1 Financial Summary
10.8.5 SWOT Analysis
10.9 LifeCodexx AG (Subsidiary of Eurofins Scientific)
10.9.1 Overview
10.10 EUROFINS Genoma Group (Subsidiary of Eurofins Scientific)
10.10.1 Overview
10.11 Eurofins Scientific
10.11.1 Overview
10.11.2 Corporate Summary
10.11.3 Product Offerings for Global NIPT Market
10.11.4 Financials
10.11.4.1 Financial Summary
10.11.5 SWOT Analysis
10.12 F. Hoffmann-La Roche AG
10.12.1 Overview
10.12.2 Corporate Summary
10.12.3 Product Offerings for Global NIPT Market
10.12.4 Financials
10.12.4.1 Financial Summary
10.12.5 SWOT Analysis
10.13 Illumina, Inc.
10.13.1 Overview
10.13.2 Corporate Summary
10.13.3 Product Offerings for Global NIPT Market
10.13.4 Financials
10.13.4.1 Financial Summary
10.13.5 SWOT Analysis
10.14 Natera, Inc.
10.14.1 Overview
10.14.2 Corporate Summary
10.14.3 Product Offerings for Global NIPT Market
10.14.4 Financials
10.14.4.1 Financial Summary
10.14.5 SWOT Analysis
10.15 Next Biosciences
10.15.1 Overview
10.15.2 Corporate Summary
10.15.3 Product Offerings for Global NIPT Market
10.15.4 SWOT Analysis
10.16 NIPD Genetics
10.16.1 Overview
10.16.2 Corporate Summary
10.16.3 Product Offerings for Global NIPT Market
10.16.4 SWOT Analysis
10.17 PerkinElmer, Inc.
10.17.1 Overview
10.17.2 Corporate Summary
10.17.3 Product Offerings for Global NIPT Market
10.17.4 Financials
10.17.4.1 Financial Summary
10.17.5 SWOT Analysis
10.18 Premaitha Health Plc
10.18.1 Overview
10.18.2 Corporate Summary
10.18.3 Product Offerings for Global NIPT Market
10.18.4 Financials
10.18.4.1 Financial Summary
10.18.5 SWOT Analysis
10.19 Quest Diagnostics Incorporated
10.19.1 Overview
10.19.2 Corporate Summary
10.19.3 Product Offerings for Global NIPT Market
10.19.4 Financials
10.19.4.1 Financial Summary
10.19.5 SWOT Analysis
10.20 Sequenom, Inc. (Subsidiary of Laboratory Corporation of America Holdings)
10.20.1 Overview
10.21 Laboratory Corporation of America Holdings
10.21.1 Overview
10.21.2 Corporate Summary
10.21.3 Product Offerings for Global NIPT Market
10.21.4 Financials
10.21.4.1 Financial Summary
10.21.5 SWOT Analysis
11 Report Scope and Methodology
11.1 Scope of the Report
11.2 Global NIPT Market Segmentation
11.3 Research Methodology
11.3.1 Primary Research
11.3.2 Secondary Research
11.3.3 Key Data Points from Primary Sources
11.3.4 Key Data Points from Secondary Sources
11.3.5 Data Triangulation
11.3.6 Top-Down Approach (Segment Wise Analysis)
11.3.7 Bottom-Up Approach (Segmental Analysis)
11.4 Assumptions and Limitations
11.5 Data and Prediction Modelling
I Annexure 1: Recent Key Developments (2014 – 2018)
II Annexure 2: Product Mapping
III Annexure 3: Patent Landscape
List of Tables
Global NIPT Market (2017 and 2028)
Major Chromosomal Aneuploidies
Incidence Rate of Major Chromosomal Aneuploidies
Technological Approach for NIPT
Impact Analysis of Market Dynamics
List of Regulatory Authorities involved in CLIA Program
List of Regulatory Bodies
NIPT Market (by Test), 2017-2028, ($Million)
NIPT Market (by Test), 2017-2028, (Units)
North America NIPT Market (by Test), 2017-2028, ($Million)
North America NIPT Market (by Test), 2017-2028, (Units)
Europe NIPT Market (by Test), 2017-2028, ($Million)
Europe NIPT Market (by Test), 2017-2028, (Units)
Europe NIPT Market (by Country), 2017-2028, ($Million)
Europe NIPT Market (by Country), 2017-2028, (Units)
Asia-Pacific NIPT Market (by Test), 2017-2028, ($Million)
Asia-Pacific NIPT Market (by Test), 2017-2028, (Units)
Asia-Pacific NIPT Market (by Country), 2017-2028, ($Million)
Asia-Pacific NIPT Market (by Country), 2017-2028, (Units)
Rest-of-the-World NIPT Market (by Test), 2017-2028, ($Million)
Rest-of-the-World NIPT Market (by Test), 2017-2028, (Units)
List of Figures
Impact of Market Drivers and Market Restraints
Market Statistics
Global NIPT Market (by Test), $Million
Global NIPT Market (by Test), Units
Global NIPT Market (by Method), 2017
Global NIPT Market (by Method), 2028
Global NIPT Market (by Application), 2017
Global NIPT Market (by Application), 2028
Global NIPT Market Value (by Region), 2017 and 2028
Global NIPT Market Volume (by Region), 2017 and 2028
Global NIPT Market (by Region), 2017
Global NIPT Market (by Region), 2028
Prenatal Testing Timeline During Pregnancy
Different Indications for NIPT
NIPT Approach
Benefits and Risks Associated with NIPT
Ecosystem Players of Global Prenatal Testing Market
Global Prenatal Testing Market: Opportunity Matrix
Global NIPT Market Value (2017-2028)
Global NIPT Market Volume (2017-2028)
Competitive Landscape (January 2014-August 2018)
Share of Key Developments and Strategies (January 2014-August 2018)
Product Launch Share, by Companies
Joint Ventures, Partnerships, and Collaborations Share, by Companies
Market Share Analysis
Growth Share Matrix (by Test), 2017
Growth Share Matrix (by Region), 2017
Porter’s Five Forces Analysis
Industry Insights (January 2014-August 2018)
Patent Share (by Assignee)
Classification of Tests in CLIA Program
NIPT Market, by Test
Global NIPT Market (by Verifi), by Revenue, 2017-2028
Global NIPT Market (by Verifi), by Volume, 2017-2028
Global NIPT Market (by MaterniT21 PLUS and MaterniT GENOME), by Revenue, 2017-2028
Global NIPT Market (by MaterniT21 PLUS and MaterniT GENOME), by Volume, 2017-2028
Global NIPT Market (by PrenaTest, GeneSafe, and PrenatalSAFE), by Revenue, 2017-2028
Global NIPT Market (by PrenaTest, GeneSafe, and PrenatalSAFE), by Volume, 2017-2028
Global NIPT Market (by Panorama), by Revenue, 2017-2028
Global NIPT Market (by Panorama), by Volume, 2017-2028
Global NIPT Market (by QNatal Advanced), by Revenue, 2017-2028
Global NIPT Market (by QNatal Advanced), by Volume, 2017-2028
Global NIPT Market (by Harmony), by Revenue, 2017-2028
Global NIPT Market (by Harmony), by Volume, 2017-2028
Global NIPT Market (by IONA), by Revenue, 2017-2028
Global NIPT Market (by IONA), by Volume, 2017-2028
Global NIPT Market (by NIFTY), by Revenue, 2017-2028
Global NIPT Market (by NIFTY), by Volume, 2017-2028
Global NIPT Market (by Bambni), by Revenue, 2017-2028
Global NIPT Market (by Bambni), by Volume, 2017-2028
Global NIPT Market (by Others), by Revenue, 2017-2028
Global NIPT Market (by Others), by Volume, 2017-2028
Global NIPT Market Share (by Method), 2017
Global NIPT Market (by Method), by Revenue, 2017-2028
Global NIPT Market (by Method), by Volume, 2017-2028
Global NIPT Market (by cf-DNA), by Revenue, 2017-2028
Global NIPT Market (by cf-DNA), by Volume, 2017-2028
Global NIPT Market (by FCMB), by Revenue, 2017-2028
Global NIPT Market (by FCMB), by Volume, 2017-2028
Global NIPT Market Share (by Platform), 2017
Global NIPT Market (by Platform), by Revenue, 2017-2028
Global NIPT Market (by Platform), by Volume, 2017-2028
Global NIPT Market (by NGS), by Revenue, 2017-2028
Global NIPT Market (by NGS), by Volume, 2017-2028
Global NIPT Market (by MPSS), by Revenue, 2017-2028
Global NIPT Market (by MPSS), by Volume, 2017-2028
Global NIPT Market (by Others), by Revenue, 2017-2028
Global NIPT Market (by Others), by Volume, 2017-2028
Global NIPT Market Share (by Application), 2017
Global NIPT Market (by Application), by Revenue, 2017-2028
Global NIPT Market (by Application), by Volume, 2017-2028
Global NIPT Market (by Trisomy Detection), by Revenue, 2017-2028
Global NIPT Market (by Trisomy Detection), by Volume, 2017-2028
Global NIPT Market (by Microdeletion Detection), by Revenue, 2017-2028
Global NIPT Market (by Microdeletion Detection), by Volume, 2017-2028
Global NIPT Market (by Others), by Revenue, 2017-2028
Global NIPT Market (by Others), by Volume, 2017-2028
Global NIPT Market (by Region), by Revenue, 2017-2028
Global NIPT Market (by Region), by Volume, 2017-2028
Global NIPT Market Share, by Region (2017)
Global NIPT Market Share, by Region (2028)
North America NIPT Market, by Revenue, 2017-2028
North America NIPT Market, by Volume, 2017-2028
North America NIPT Market (by Country), by Revenue, 2017-2028
North America NIPT Market (by Country), by Volume, 2017-2028
The U.S. NIPT Market, by Revenue, 2017-2028
The U.S. NIPT Market, by Volume, 2017-2028
Canada NIPT Market, by Revenue, 2017-2028
Canada NIPT Market, by Volume, 2017-2028
Europe NIPT Market, by Revenue, 2017-2028
Europe NIPT Market, by Volume, 2017-2028
The U.K. NIPT Market, by Revenue, 2017-2028
The U.K. NIPT Market, by Volume, 2017-2028
Germany NIPT Market, by Revenue, 2017-2028
Germany NIPT Market, by Volume, 2017-2028
France NIPT Market, by Revenue, 2017-2028
France NIPT Market, by Volume, 2017-2028
Italy NIPT Market, by Revenue, 2017-2028
Italy NIPT Market, by Volume, 2017-2028
Spain NIPT Market, by Revenue, 2017-2028
Spain NIPT Market, by Volume, 2017-2028
The Netherlands NIPT Market, by Revenue, 2017-2028
The Netherlands NIPT Market, by Volume, 2017-2028
Belgium NIPT Market, by Revenue, 2017-2028
Belgium NIPT Market, by Volume, 2017-2028
Switzerland NIPT Market, by Revenue, 2017-2028
Switzerland NIPT Market, by Volume, 2017-2028
Sweden NIPT Market, by Revenue, 2017-2028
Sweden NIPT Market, by Volume, 2017-2028
Denmark NIPT Market, by Revenue, 2017-2028
Denmark NIPT Market, by Volume, 2017-2028
Poland NIPT Market, by Revenue, 2017-2028
Poland NIPT Market, by Volume, 2017-2028
Russia NIPT Market, by Revenue, 2017-2028
Russia NIPT Market, by Volume, 2017-2028
Rest-of-Europe NIPT Market, by Revenue, 2017-2028
Rest-of-Europe NIPT Market, by Volume, 2017-2028
Asia-Pacific NIPT Market, by Revenue, 2017-2028
Asia-Pacific NIPT Market, by Volume, 2017-2028
China NIPT Market, by Revenue, 2017-2028
China NIPT Market, by Volume, 2017-2028
Japan NIPT Market, by Revenue, 2017-2028
Japan NIPT Market, by Volume, 2017-2028
Australia NIPT Market, by Revenue, 2017-2028
Australia NIPT Market, by Volume, 2017-2028
India NIPT Market, by Revenue, 2017-2028
India NIPT Market, by Volume, 2017-2028
Singapore NIPT Market, by Revenue, 2017-2028
Singapore NIPT Market, by Volume, 2017-2028
Hong Kong NIPT Market, by Revenue, 2017-2028
Hong Kong NIPT Market, by Volume, 2017-2028
Malaysia NIPT Market, by Revenue, 2017-2028
Malaysia NIPT Market, by Volume, 2017-2028
Indonesia NIPT Market, by Revenue, 2017-2028
Indonesia NIPT Market, by Volume, 2017-2028
Vietnam NIPT Market, by Revenue, 2017-2028
Vietnam NIPT Market, by Volume, 2017-2028
South Korea NIPT Market, by Revenue, 2017-2028
South Korea NIPT Market, by Volume, 2017-2028
Philippines NIPT Market, by Revenue, 2017-2028
Philippines NIPT Market, by Volume, 2017-2028
Thailand NIPT Market, by Revenue, 2017-2028
Thailand NIPT Market, by Volume, 2017-2028
Rest-of-Asia-Pacific NIPT Market, by Revenue, 2017-2028
Rest-of-Asia-Pacific NIPT Market, by Volume, 2017-2028
Rest-of-the-World NIPT Market, by Revenue, 2017-2028
Rest-of-the-World NIPT Market, by Volume, 2017-2028
Share of Key Company Profiles (by Company Type)
Agilent Technologies, Inc.: Overall Product Portfolio
Agilent Technologies, Inc.: Product Portfolio for Global NIPT Market
Agilent Technologies, Inc.: Overall Financials (2015-2017)
Agilent Technologies, Inc.: Revenue by Business Segments (2015-2017)
Agilent Technologies, Inc.: Revenue by Region (2015-2017)
Agilent Technologies, Inc.: SWOT Analysis
Annoroad Gene Technology: Overall Product Portfolio
Annoroad Gene Technology: Product Portfolio for Global NIPT Market
Annoroad Gene Technology: SWOT Analysis
Berry Genomics Co., Ltd.: Overall Product Portfolio
Berry Genomics Co., Ltd.: Product Portfolio for Global NIPT Market
Berry Genomics Co., Ltd.: SWOT Analysis
BGI Diagnosis: Overall Product Portfolio
BGI Diagnosis: Product Portfolio for Global NIPT Market
BGI Diagnosis: SWOT Analysis
Centogene AG: Overall Product Portfolio
Centogene AG: Product Portfolio for Global NIPT Market
Centogene AG: SWOT Analysis
Myriad Genetics, Inc.: Overall Product Portfolio
Myriad Genetics, Inc.: Product Offerings for Global NIPT Market
Myriad Genetics, Inc.: Overall Financials (2015-2017)
Myriad Genetics, Inc.: Net Revenue by Business Segment (2015-2017)
Myriad Genetics, Inc.: SWOT Analysis
Eurofins Scientific: Overall Product Portfolio
Eurofins Scientific: Product Offerings for Global NIPT Market
Eurofins Scientific: Overall Financials (2015-2017)
Eurofins Scientific: Net Revenue by Region (2015-2017)
Eurofins Scientific: SWOT Analysis
F. Hoffmann-La Roche AG: Overall Product Portfolio
F. Hoffmann-La Roche AG: Product Portfolio for Global NIPT Market
F. Hoffmann-La Roche AG: Overall Financials (2015-2017)
F. Hoffmann-La Roche AG: Net Revenue by Business Segment (2015-2017)
F. Hoffmann-La Roche AG: Net Revenue by Diagnostics Sub-division (2015-2017)
F. Hoffmann-La Roche AG: Net Revenue by Region (2015-2017)
F. Hoffmann-La Roche AG: SWOT Analysis
Illumina, Inc.: Overall Product Portfolio
Illumina, Inc.: Product Offerings for Global NIPT Market
Illumina, Inc.: Overall Financials (2015-2017)
Illumina, Inc.: Net Revenue by Business Segment (2015-2017)
Illumina, Inc.: Net Revenue by Region (2015-2017)
Illumina, Inc.: SWOT Analysis
Natera, Inc.: Overall Product Portfolio
Natera, Inc.: Product Offerings for Global NIPT Market
Natera, Inc.: Overall Financials (2015-2017)
Natera, Inc.: Revenue by Region (2015-2017)
Natera, Inc.: SWOT Analysis
Next Biosciences: Overall Product Portfolio
Next Biosciences: Product Portfolio for Global NIPT Market
Next Biosciences: SWOT Analysis
NIPD Genetics: Overall Product Portfolio
NIPD Genetics: Product Portfolio for Global NIPT Market
NIPD Genetics : SWOT Analysis
PerkinElmer, Inc.: Overall Product Portfolio
PerkinElmer, Inc.: Product Portfolio for Global NIPT Market
PerkinElmer, Inc.: Overall Financials (2015-2017)
PerkinElmer, Inc.: Net Revenue by Business Segment (2015-2017)
PerkinElmer, Inc.: Net Revenue by Region (2015-2017)
PerkinElmer, Inc.: SWOT Analysis
Premaitha Health Plc: Overall Product Portfolio
Premaitha Health Plc: Product Portfolio for Global NIPT Market
Premaitha Health: Overall Financials (2015-2017)
Premaitha Health: Net Revenue by Region (2015-2017)
Premaitha Health Plc: SWOT Analysis
Quest Diagnostics Incorporated: Overall Product Portfolio
Quest Diagnostics Incorporated: Product Portfolio for Global NIPT Market
Quest Diagnostics Incorporated: Overall Financials (2015-2017)
Quest Diagnostics Incorporated: Net Revenue by Business Segment (2015-2017)
Quest Diagnostics Incorporated: Net Revenue by DIS Segment (2015-2017)
Quest Diagnostics Incorporated: SWOT Analysis
Laboratory Corporation of America Holdings : Overall Product Portfolio
Laboratory Corporation of America Holdings: Product Offerings for Global NIPT Market
Laboratory Corporation of America Holdings: Overall Financials (2015-2017)
Laboratory Corporation of America Holdings: Net Revenue by Business Segment (2015-2017)
Laboratory Corporation of America Holdings: Net Revenue by Region (2015-2017)
Laboratory Corporation of America Holdings: SWOT Analysis
Global NIPT Market Segmentation
Considered Factors for Data Prediction and Modeling

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report